Ursina Teitelbaum
University of Pennsylvania(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans(2011)1,617 cited
- → A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma(2013)447 cited
- → Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer(2019)281 cited
- → Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2(2021)230 cited
- → Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial(2022)129 cited
- → The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)(2015)104 cited
- → Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma(2011)97 cited
- → A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma(2013)89 cited
- → Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer(2020)49 cited
- → Peptide Receptor Radionuclide Therapy–Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors(2015)48 cited